Results
1 -
10 of
32B. Stensland and R. J. Roberts.
N-(3-Methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide (ZD4054 Form 1), Acta Cryst. (2004). E60, o1817-o1819Â Â Â Â Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate, Managing Metastatic Prostate Cancer In Your Urological Oncology Practice Imaging of Glycolysis with 18F-FDG PET, Bone Metastases from Prostate Cancer New Targeted Therapies for Bone Metastases, Bone Metastases Trials and Tribulations in Prostate Cancer, Pharmaceutical & Diagnostic Innovation Endothelin, Cellular and Molecular Life Sciences Association of oral endothelin receptor antagonists with risks of cardiovascular events and mortality: meta-analysis of randomized controlled trials, European Journal of Clinical Pharmacology Novel options for the treatment of castration-resistant prostate cancer, World Journal of Urology